Navidea Biopharmaceuticals
NAVBQPhase 3Navidea Biopharmaceuticals, Inc. is a leader in precision medicine with immuno-targeted products.
Market Cap
$10K
Focus
DiagnosticsRadiopharmaceuticals
NAVBQ · Stock Price
USD 0.000.00 (-50.00%)
Historical price data
About
Navidea Biopharmaceuticals, Inc. is a leader in precision medicine with immuno-targeted products.
Pipeline Snapshot
2020 drugs in pipeline, 7 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Lymphoseek | Breast Cancer | Phase 3 | |
| Lymphoseek | Breast Cancer | Phase 3 | |
| NAV5001 + DaTscan | Parkinson's Syndrome | Phase 3 | |
| [18F]NAV4694 | Dementia | Phase 3 | |
| NAV5001 | Parkinson's Syndrome | Phase 3 |
Company Info
TypePublic
LocationUnited States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile